These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27576065)

  • 1. Biospecimen User Fees: Global Feedback on a Calculator Tool.
    Matzke LA; Babinszky S; Slotty A; Meredith A; Castillo-Pelayo T; Henderson MK; Simeon-Dubach D; Schacter B; Watson PH
    Biopreserv Biobank; 2017 Feb; 15(1):57-64. PubMed ID: 27576065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical tool for modeling biospecimen user fees.
    Matzke L; Dee S; Bartlett J; Damaraju S; Graham K; Johnston R; Mes-Masson AM; Murphy L; Shepherd L; Schacter B; Watson PH
    Biopreserv Biobank; 2014 Aug; 12(4):234-9. PubMed ID: 25162459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap.
    Barnes RO; Schacter B; Kodeeswaran S; ; Watson PH
    Biopreserv Biobank; 2014 Oct; 12(5):300-5. PubMed ID: 25314324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet).
    Matzke EA; O'Donoghue S; Barnes RO; Daudt H; Cheah S; Suggitt A; Bartlett J; Damaraju S; Johnston R; Murphy L; Shepherd L; Mes-Masson AM; Schacter B; Watson PH
    Biopreserv Biobank; 2012 Oct; 10(5):426-32. PubMed ID: 24845043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobank classification in an Australian setting.
    Rush A; Christiansen JH; Farrell JP; Goode SM; Scott RJ; Spring KJ; Byrne JA
    Biopreserv Biobank; 2015 Jun; 13(3):212-8. PubMed ID: 26035012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
    Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current modalities and concepts on access and use of biospecimen samples and associated data for research from human biobanks].
    Siddiqui R; Semler SC
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):317-24. PubMed ID: 26809822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey.
    Rush A; Catchpoole DR; Reaiche-Miller G; Gilbert T; Ng W; Watson PH; Byrne JA
    Biopreserv Biobank; 2022 Jun; 20(3):271-282. PubMed ID: 34756100
    [No Abstract]   [Full Text] [Related]  

  • 14. Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues.
    Abdelhafiz AS; Sultan EA; Ziady HH; Sayed DM; Khairy WA
    PLoS One; 2021; 16(3):e0248401. PubMed ID: 33770108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Impacts of the Generic Drug User Fee Act Fee Structure.
    Dong K; Boehm G; Zheng Q
    Value Health; 2017 Jun; 20(6):792-798. PubMed ID: 28577697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Canadian Tissue Repository Network Biobank Certification and the College of American Pathologists Biorepository Accreditation Programs: Two Strategies for Knowledge Dissemination in Biobanking.
    Barnes RO; Shea KE; Watson PH
    Biopreserv Biobank; 2017 Feb; 15(1):9-16. PubMed ID: 27740852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience.
    Barnes R; Albert M; Damaraju S; de Sousa-Hitzler J; Kodeeswaran S; Mes-Masson AM; Watson P; Schacter B
    Biopreserv Biobank; 2013 Dec; 11(6):387-96. PubMed ID: 24835369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.